We are live on ! Find out more
GSK icon

GSK
GSK

763 hedge funds and large institutions have $9.69B invested in GSK in 2017 Q4 according to their latest regulatory filings, with 135 funds opening new positions, 168 increasing their positions, 348 reducing their positions, and 109 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more first-time investments, than exits

New positions opened: 135 | Existing positions closed: 109

3% more funds holding

Funds holding: 741 → 763 (+22)

7% more call options, than puts

Call options by funds: $107M | Put options by funds: $99.7M

0.46% more ownership

Funds ownership: 3.95% → 4.41% (+0.46%)

2% less capital invested

Capital invested by funds: $9.84B → $9.69B (-$148M)

10% less funds holding in top 10

Funds holding in top 10: 10 → 9 (-1)

52% less repeat investments, than reductions

Existing positions increased: 168 | Existing positions reduced: 348

Holders
763
Holders Change
+22
Holders Change %
+2.97%
% of All Funds
17.31%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.2%
New
135
Increased
168
Reduced
348
Closed
109
Calls
$107M
Puts
$99.7M
Net Calls
+$7.16M
Net Calls Change
-$43.6M

Top Buyers

Rank Fund Capital Flow
1
Dodge & Cox
Dodge & Cox
California
+$1.08B
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$624M
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$66.9M
4
CCM
Camber Capital Management
Massachusetts
+$55.4M
5
Millennium Management
Millennium Management
New York
+$48.7M

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$197M
2
Bank of America
Bank of America
North Carolina
-$125M
3
HCM
Hamlin Capital Management
New York
-$72M
4
MHI
Miller Howard Investments
New York
-$56.4M
5
Morgan Stanley
Morgan Stanley
New York
-$38.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
SMG
801
Spectrum Management Group
Indiana
– -$505K -9,960 Closed
CAAS
802
Capital Asset Advisory Services
Michigan
– -$498K -9,806 Closed
PCM
803
Perkins Capital Management
Minnesota
– -$483K -9,520 Closed
NPC
804
National Planning Corporation
California
– -$453K -8,935 Closed
KWMG
805
King Wealth Management Group
Florida
– -$442K -8,712 Closed
RWM
806
RKL Wealth Management
Pennsylvania
– -$425K -8,434 Closed
BCAM
807
Boston Common Asset Management
Massachusetts
– -$424K -8,356 Closed
OCG
808
Opus Capital Group
Ohio
– -$399K -7,856 Closed
NFG
809
Next Financial Group
Texas
– -$401K -7,822 Closed
TYCC
810
Texas Yale Capital Corp
Florida
– -$375K -7,398 Closed
CS
811
Credential Securities
– -$373K -7,346 Closed
SCM
812
Stevens Capital Management
Pennsylvania
– -$353K -6,956 Closed
MC
813
Mathes Company
New York
– -$341K -6,720 Closed
GWM
814
GSB Wealth Management
Connecticut
– -$336K -6,616 Closed
GIA
815
Guyasuta Investment Advisors
Pennsylvania
– -$333K -6,554 Closed
GD
816
Grandfield & Dodd
New York
– -$296K -5,837 Closed
DHFB
817
Dixon Hubard Feinour & Brown
Virginia
– -$293K -5,764 Closed
BFC
818
Blue Fin Capital
Rhode Island
– -$289K -5,700 Closed
PFS
819
Prospera Financial Services
Texas
– -$284K -5,571 Closed
WSTAM
820
Wilbanks Smith & Thomas Asset Management
Virginia
– -$276K -5,430 Closed
JWS
821
Juncture Wealth Strategies
Arizona
– -$272K -5,360 Closed
SA
822
Strategic Advisors
New York
– -$269K -5,292 Closed
RCAG
823
Rehmann Capital Advisory Group
Michigan
– -$264K -5,207 Closed
RC
824
RegentAtlantic Capital
New Jersey
– -$262K -5,167 Closed
CL
825
Choreo LLC
Illinois
– -$265K -5,154 Closed
31 32
33
34 35

GSK Hedge Fund Activity: Q4 2017 in Review

763 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q4 2017, worth a combined $9.69B — down 1.5% from $9.84B a quarter earlier.

Buyers outnumbered sellers: 135 funds opened new GSK positions and 109 closed out — a net gain of 26 holders — while 168 added to existing stakes and 348 trimmed.

The largest buyer was Dodge & Cox, adding an estimated $1.08B. The largest seller was Wells Fargo, cutting an estimated $197M.

  • 763 institutional investors held GSK (GSK) as of Q4 2017, up from 741 in Q3 2017.
  • Funds reported $9.69B of GSK stock for Q4 2017, down 1.5% quarter-over-quarter.
  • 135 funds opened new GSK positions in Q4 2017 and 109 closed out, a net change of +26 holders.
  • The largest GSK buyer in Q4 2017 was Dodge & Cox, an estimated $1.08B added.
  • The largest GSK seller in Q4 2017 was Wells Fargo, an estimated $197M sold.

Based on aggregated 13F filings for Q4 2017.